-
1
-
-
3242677099
-
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial
-
Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
-
(2004)
Lancet
, vol.364
, pp. 263-269
-
-
Grigor, C.1
Capell, H.2
Stirling, A.3
-
2
-
-
27744514865
-
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). A randomised controlled trial
-
Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study). A randomised controlled trial. Arthritis Rheum 2005; 52:3381-90.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3381-3390
-
-
Goekoop-Ruiterman, Y.P.M.1
de Vries-Bouwstra, J.K.2
Allaart, C.F.3
-
3
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
-
4
-
-
0345072560
-
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset
-
Wallberg-Jonsson S, Johanson H, Ohman ML, Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
-
(1999)
J Rheumatol
, vol.26
, pp. 2562-2571
-
-
Wallberg-Jonsson, S.1
Johanson, H.2
Ohman, M.L.3
Rantapaa-Dahlqvist, S.4
-
5
-
-
28544447858
-
Disease modification and cardiovascular risk reduction: Two sides of the same coin?
-
Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: Two sides of the same coin? Rheumatology 2005; 44:1473-82.
-
(2005)
Rheumatology
, vol.44
, pp. 1473-1482
-
-
Hall, F.C.1
Dalbeth, N.2
-
6
-
-
0141893577
-
Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids
-
Morrison E, Crosbie D, Capell HA. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology 2003; 42:1247-50.
-
(2003)
Rheumatology
, vol.42
, pp. 1247-1250
-
-
Morrison, E.1
Crosbie, D.2
Capell, H.A.3
-
7
-
-
0029969623
-
Corticosteroids in the management of rheumatoid arthritis
-
Morrison E, Capell HA. Corticosteroids in the management of rheumatoid arthritis. Br J Rheumatol 1996;35:2-4.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 2-4
-
-
Morrison, E.1
Capell, H.A.2
-
8
-
-
0032725844
-
Corticosteroids in rheumatoid arthritis - The case against
-
Morrison E, Capell HA. Corticosteroids in rheumatoid arthritis - the case against. Rheumatology 1999;38:97-100.
-
(1999)
Rheumatology
, vol.38
, pp. 97-100
-
-
Morrison, E.1
Capell, H.A.2
-
9
-
-
0029053188
-
The effect of glucocorticoids on joint destruction in rheumatoid arthritis
-
and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
-
Kirwan J, and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
-
(1995)
N Engl J Med
, vol.333
, pp. 142-146
-
-
Kirwan, J.1
-
10
-
-
0030751946
-
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
-
Boers M, Verhoven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
-
(1997)
Lancet
, vol.350
, pp. 309-318
-
-
Boers, M.1
Verhoven, A.C.2
Markusse, H.M.3
-
11
-
-
0036140321
-
Low-dose prednisolone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side-effects: A randomised, double-blind, placebo-controlled clinical trial
-
van Everdingen AA, Jacobs JW, Siewertsz van Reesma DR, Bijlsma JW. Low-dose prednisolone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side-effects: A randomised, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
-
(2002)
Ann Intern Med
, vol.136
, pp. 1-12
-
-
van Everdingen, A.A.1
Jacobs, J.W.2
Siewertsz van Reesma, D.R.3
Bijlsma, J.W.4
-
12
-
-
3042739344
-
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: Results of a randomised controlled trial
-
Capell HA, Madhok R, Hunter JA et al. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: Results of a randomised controlled trial. Ann Rheum Dis 2004;63:797-803.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 797-803
-
-
Capell, H.A.1
Madhok, R.2
Hunter, J.A.3
-
13
-
-
27744525171
-
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. A multicenter, double-blind, placebo-controlled trial
-
for the Low-dose Prednisolone Therapy Study Group
-
Wassenberg S, Rau R, Steinfeld P, Zeidler H, for the Low-dose Prednisolone Therapy Study Group. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. A multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:3371-80.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3371-3380
-
-
Wassenberg, S.1
Rau, R.2
Steinfeld, P.3
Zeidler, H.4
-
14
-
-
27744466694
-
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. A two year randomised trial
-
for the BARFOT Study Group
-
Svensson B, Boonen A, Albertsson K, van der Heijde, Kellar C, Hafström I, for the BARFOT Study Group. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. A two year randomised trial. Arthritis Rheum 2005;52:3360-70.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3360-3370
-
-
Svensson, B.1
Boonen, A.2
Albertsson, K.3
van der Heijde4
Kellar, C.5
Hafström, I.6
-
15
-
-
0031696828
-
Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis
-
and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
-
Hickling P, Jacoby RK, Kirwan JR. and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998;37:930-6.
-
(1998)
Br J Rheumatol
, vol.37
, pp. 930-936
-
-
Hickling, P.1
Jacoby, R.K.2
Kirwan, J.R.3
-
16
-
-
0016211783
-
Minimisation: A new method of assigning patients to treatment and control groups
-
Taves DR. Minimisation: A new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974;15:443-53.
-
(1974)
Clin Pharmacol Ther
, vol.15
, pp. 443-453
-
-
Taves, D.R.1
-
17
-
-
0032497095
-
Minimisation: The platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does
-
(Editorial)
-
Treasure T, MacRae KD. Minimisation: The platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does (Editorial). Br Med J 1998;317:362-3.
-
(1998)
Br Med J
, vol.317
, pp. 362-363
-
-
Treasure, T.1
MacRae, K.D.2
-
18
-
-
84958107344
-
The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report
-
Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report. Proc Staff Meet Mayo Clin 1949;24:181-97.
-
(1949)
Proc Staff Meet Mayo Clin
, vol.24
, pp. 181-197
-
-
Hench, P.S.1
Kendall, E.C.2
Slocumb, C.H.3
Polley, H.F.4
-
19
-
-
70449169625
-
Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years treatment
-
Empire Rheumatism Council
-
Empire Rheumatism Council. Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years treatment. Ann Rheum Dis 1957;16:277-89.
-
(1957)
Ann Rheum Dis
, vol.16
, pp. 277-289
-
-
-
20
-
-
33144484825
-
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data
-
Da Silva JAP, Jacobs JWG, Kirwan JR et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data. Ann Rheum Dis 2006;65:285-93.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 285-293
-
-
Da Silva, J.A.P.1
Jacobs, J.W.G.2
Kirwan, J.R.3
-
21
-
-
26444573183
-
Steroids for Rheumatoid Arthritis: The honeymoon revisited (once again)
-
Caplan L, Russell AS, Wolf F. Steroids for Rheumatoid Arthritis: The honeymoon revisited (once again). J Rheumatol 2005;32:1863-5.
-
(2005)
J Rheumatol
, vol.32
, pp. 1863-1865
-
-
Caplan, L.1
Russell, A.S.2
Wolf, F.3
-
22
-
-
27744500020
-
Prednisolone in Early Rheumatoid Arthritis: An antiinvasive Effect
-
Harris ED. Prednisolone in Early Rheumatoid Arthritis: An antiinvasive Effect. Arthritis Rheum 2005;52:3324-5.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3324-3325
-
-
Harris, E.D.1
-
23
-
-
0023112518
-
Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis
-
Hansen TM, Dickmeiss E, Jans H, Hansen TI, Ingeman-Nielsen M, Lorenzen IB. Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Annals Rheum Dis 1987;46:290-5.
-
(1987)
Annals Rheum Dis
, vol.46
, pp. 290-295
-
-
Hansen, T.M.1
Dickmeiss, E.2
Jans, H.3
Hansen, T.I.4
Ingeman-Nielsen, M.5
Lorenzen, I.B.6
-
24
-
-
0025280914
-
Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24 week randomised controlled trial
-
Corkill MM, Kirkham BW, Chikanza C, Gibson T, Panayi G. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24 week randomised controlled trial. Br J Rheumatol 1990;29:274-9.
-
(1990)
Br J Rheumatol
, vol.29
, pp. 274-279
-
-
Corkill, M.M.1
Kirkham, B.W.2
Chikanza, C.3
Gibson, T.4
Panayi, G.5
-
25
-
-
0025296394
-
Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis
-
Hansen TM, Kryger P, Elling H et al. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. Br Med J 1990;301:268-70.
-
(1990)
Br Med J
, vol.301
, pp. 268-270
-
-
Hansen, T.M.1
Kryger, P.2
Elling, H.3
-
26
-
-
0028997898
-
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double-blind placebo-controlled trial
-
Van Gestel AM, Laan RFJM, Haagsma CJ, Van de Putte LBA, Van Riel PLCM. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double-blind placebo-controlled trial. Br J Rheumatol 1995;34:347-51.
-
(1995)
Br J Rheumatol
, vol.34
, pp. 347-351
-
-
Van Gestel, A.M.1
Laan, R.F.J.M.2
Haagsma, C.J.3
Van de Putte, L.B.A.4
Van Riel, P.L.C.M.5
-
27
-
-
0029967615
-
A randomised double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis
-
Ciconelli RM, Ferraz MB, Visioni RA, Oliveira LM, Atra E. A randomised double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1996;35:150-4.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 150-154
-
-
Ciconelli, R.M.1
Ferraz, M.B.2
Visioni, R.A.3
Oliveira, L.M.4
Atra, E.5
-
28
-
-
0028273838
-
Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events
-
Saag KG, Koehke R, Caldwell JR et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. American J Med 1994;96:115-23.
-
(1994)
American J Med
, vol.96
, pp. 115-123
-
-
Saag, K.G.1
Koehke, R.2
Caldwell, J.R.3
-
29
-
-
23944483180
-
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
-
the Intramuscular Methylprednisolone Study Group
-
Choy EH, Kingsley GH, Khoshaba B, Pipitone N, Scott DL, the Intramuscular Methylprednisolone Study Group. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Ann Rheum Dis 2005;64:1288-93.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 1288-1293
-
-
Choy, E.H.1
Kingsley, G.H.2
Khoshaba, B.3
Pipitone, N.4
Scott, D.L.5
-
30
-
-
4344578260
-
A randomised comparative study of the short term clinical and biological benefits of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
-
Durez P, Nzeusseu Toukap A, Lauwerys BR et al. A randomised comparative study of the short term clinical and biological benefits of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Ann Rheum Dis 2004;63:1069-74.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1069-1074
-
-
Durez, P.1
Nzeusseu Toukap, A.2
Lauwerys, B.R.3
-
31
-
-
24944573479
-
Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: A randomised controlled study
-
Furtado RNV, Olivera LM, Natour J. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: A randomised controlled study. J Rheumatol 2005; 32:1691-8.
-
(2005)
J Rheumatol
, vol.32
, pp. 1691-1698
-
-
Furtado, R.N.V.1
Olivera, L.M.2
Natour, J.3
-
32
-
-
26444519878
-
Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: What is the true direction of the effect?
-
Davis JM, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: What is the true direction of the effect? J Rheumatol 2005;32:1856-62.
-
(2005)
J Rheumatol
, vol.32
, pp. 1856-1862
-
-
Davis, J.M.1
Maradit-Kremers, H.2
Gabriel, S.E.3
-
33
-
-
0035676529
-
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
-
del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2737-2745
-
-
del Rincón, I.1
Williams, K.2
Stern, M.P.3
Freeman, G.L.4
Escalante, A.5
|